What Should Prescribers and Policy Makers Know About US Drug Importation?

Nisha Quasba, Elliot Vice
{"title":"What Should Prescribers and Policy Makers Know About US Drug Importation?","authors":"Nisha Quasba, Elliot Vice","doi":"10.1001/amajethics.2024.295","DOIUrl":null,"url":null,"abstract":"Drug importation raises several ethical and safety concerns relevant to prescribers and policy makers considering costs and benefits of international medicine importation. This article suggests key points to consider, especially from a policy perspective, when weighing imported medicines' perceived affordability and accessibility against additional resource expenditure needed to assure sufficient regulatory oversight and equitable distribution and to mitigate potential risks of harm to patients.","PeriodicalId":505099,"journal":{"name":"AMA Journal of Ethics","volume":"259 1","pages":"E295-302"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AMA Journal of Ethics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/amajethics.2024.295","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Drug importation raises several ethical and safety concerns relevant to prescribers and policy makers considering costs and benefits of international medicine importation. This article suggests key points to consider, especially from a policy perspective, when weighing imported medicines' perceived affordability and accessibility against additional resource expenditure needed to assure sufficient regulatory oversight and equitable distribution and to mitigate potential risks of harm to patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
处方者和政策制定者应该了解美国药品进口的哪些情况?
对于处方者和考虑国际药品进口成本和收益的政策制定者来说,药品进口引发了一些道德和安全问题。本文提出了在权衡进口药品的可负担性和可获得性与为确保充分的监管监督和公平分配所需的额外资源支出以及降低对患者造成伤害的潜在风险时应考虑的要点,尤其是从政策角度出发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
How Should Health Care Organizations Limit Roles of Human Trafficking in Their Labor and Supply Chains? Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains? AMA Code of Medical Ethics’ Opinions Related to Global Medical Supply Chain Security How Should We Draw on Pharmacists' Expertise to Manage Drug Shortages in Hospitals? Surveillance and Security in US Medicine and Equipment Supply Chains.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1